Polychromatic Phototherapy Device with Segmented UV and LED Modules
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for various illnesses, such as auto-immune, viral, bacterial, and fungal diseases, are inadequate in restoring the body's ability to buffer free radicals and activate immune function, leading to ineffective immune responses and poor cellular metabolism.
Innovation Solution
A polychromatic phototherapy device that applies multiple sources of UV and LED light to blood, emitting dual wavelengths in the UVA and UVC range, along with visible spectrum light, to deactivate pathogens' DNA, enhance immune response, and promote mitochondrial energy production, thereby creating an autogenous 'vaccine' effect and increasing antibody production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If multiple UV and LED light sources are applied to blood, then pathogen deactivation and immune response enhancement are improved, but device complexity increases
Solution Approach 1:
The device divides the light therapy function into separate UV and LED modules, each targeting specific pathogen types or mechanisms. The UV section handles viral inactivation while LED sections address bacterial and fungal pathogens, allowing specialized treatment for different pathogen categories without requiring a single complex multi-functional unit.
Solution Approach 2:
The phototherapy device is designed to treat multiple pathogen types (viral, bacterial, fungal) and multiple conditions (auto-immune, viral, bacterial, fungal diseases) within a single system. The combination of UV and LED light sources provides universal pathogen deactivation capability across different disease categories, making one device applicable to many therapeutic scenarios.
2Reliability
If multiple UV and LED light sources are applied to blood, then immune function activation and antibody production are improved, but treatment time increases
Solution Approach 1:
The device performs preliminary pathogen deactivation during the phototherapy treatment itself, before the blood is reinfused into the patient. By pre-treating the blood sample to destroy pathogens and activate immune function, the system eliminates the need for post-treatment isolation or additional processing steps, thereby reducing overall treatment time while maintaining effective immune activation.
Solution Approach 2:
The phototherapy process maintains continuous blood circulation through the treatment chamber, ensuring uninterrupted exposure to light sources. The system keeps blood flowing continuously through the UV and LED treatment zones, maximizing the effective treatment duration without idle time, thereby achieving strong immune activation within a compact treatment window.
3Use of energy by moving object
If high energy light sources are used, then photonic energy delivery is improved, but risk of DNA damage to host cells increases
Solution Approach 1:
The device applies different light qualities to different parts of the blood sample. UV light is concentrated on pathogen inactivation in specific zones, while LED light provides broader spectrum coverage for immune activation. This localized application of specific wavelengths ensures high photonic energy delivery to pathogens while minimizing exposure of host cells to potentially damaging high-energy UV radiation.
Solution Approach 2:
The system converts the potentially harmful effect of UV light on host DNA into a beneficial pathogen deactivation mechanism. By controlling UV exposure parameters and combining it with LED therapy, the device achieves selective pathogen inactivation while the immune system benefits from the controlled stress response, transforming what could be harmful into a therapeutic advantage for vaccine-like immunity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The device effectively deactivates pathogens, enhances immune response, improves oxygenation, and increases antibody production, providing a minimally invasive treatment for chronic and acute conditions, including diseases like Dengue, Zika, HIV, and septicemia, by delivering wide-spectrum photonic energy to the blood.
Implementation Method 1
Ultraviolet light exposure to the blood and its components can result in damage to the DNA of pathogens, killing them and/or rendering them unable to replicate
Implementation Method 2
Ultraviolet light exposure to the blood and its components can result in damage to the DNA of pathogens
Implementation Method 3
The application of oxidative and light therapy in measured doses restores the body's ability to buffer free radicals, activate immune function, and correct cellular metabolism
Implementation Method 4
60 watts of highly focused LED light sources in the visible spectrum
Data Source
AI summary
A polychromatic phototherapy device for blood treatment including a casing having a triple quartz tube cuvette assembly removably installed in the casing, with blood to be treated passing through the cuvette. A plurality of light sources are mounted in the casing adjacent the cuvette to project focused light onto the blood flowing through the cuvette. The light sources include a dual wavelength UVA light source, a UVC light source, and dual wavelength red, an amber, a green and a blue LED light sources. Each of the LED light sources includes a lens assembly that projects a concentrated, highly focused linear light beam on one of the quartz tubes of the cuvette through which the blood is flowing. Once blood has been withdrawn from a patient and treated in the polychromatic phototherapy device, the blood is reinfused back into the patient.